Unraveling the enigma of spinal cord schistosomosis: clinical spectrum, diagnosis, and therapeutic insights
DOI:
https://doi.org/10.17420/ap71.539Keywords:
spine, spinal cord, schistosomosis, bilharziosis, parasiteAbstract
Spinal cord schistosomosis is a rare but significant cause of myelopathy, ranging from asymptomatic egg deposits to severe transverse myelitis. Common in endemic regions, S. mansoni myelopathy presents as acute paraplegia or cauda equina syndrome. Diagnosis involves identifying ova in stool, urine, or rectal biopsy, accompanied by peripheral eosinophilia. Treatment includes praziquantel and corticosteroids, with laminectomy reserved for specific cases. Prognosis varies, with around one-third recovering completely, one-third with residual deficits, and one-third remaining unchanged or deteriorating, particularly in necrotic myelitis. Recognition in endemic areas is critical for timely intervention and improved outcomes in this potentially treatable myelopathy.
References
[1] Ross A.G.P., Bartley P.B., Sleigh A.C., Olds G.R., Li Y., Williams G.M., McManus D.P. 2002. Schistosomiasis. New England Journal of Medicine 346(16): 1212–1220. https://doi.org/10.1056/NEJMra012396
[2] Chitsulo L., Engels D., Montresor A., Savioli L. 2000. The global status of schistosomiasis and its control. Acta Tropica 77(1): 41–51. https://doi.org/10.1016/s0001-706x(00)00122-4
[3] Clerinx J., Van Gompel A. 2011. Schistosomiasis in travellers and migrants. Travel Medicine and Infectious Disease 9(1): 6–24. https://doi.org/10.1016/j.tmaid.2010.11.002
[4] Ferrari T.C.A., Moreira P.R.R. 2011. Neuro - schistosomiasis: clinical symptoms and pathogenesis. The Lancet Neurology 10(9): 853–864. https://doi.org/10.1016/S1474-4422(11)70170-3
[5] Carod-Artal F.J. 2010. Neuroschistosomiasis. Expert Review of Anti-Infective Therapy 8(11): 1307–1318. https://doi.org/10.1586/eri.10.111
[6] Di Bella S., Riccardi N., Giacobbe D.R., Luzzati R. 2018. History of schistosomiasis (Bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies. Pathogens and Global Health 112(5): 268–273. https://doi.org/10.1080/20477724.2018.1495357
[7] Gryseels B., Polman K., Clerinx J., Kestens L. 2006. Human schistosomiasis. Lancet 368: 1106–1118. https://doi.org/10.1016/S0140-6736(06)69440-3
[8] Olveda D.U., Olveda R.M., McManus D.P., Cai P., Chau T.N., Lam A.K., Li Y., Harn D.A., Vinluan M.L., Ross A.G. 2014. The chronic enteropathogenic disease schistosomiasis. International Journal of Infectious Diseases 28: 193–203. https://doi.org/10.1016/j.ijid.2014.07.009
[9] Gray D.J., McManus D.P., Li Y., Williams G.M., Bergquist R., Ross A.G. 2010. Schistosomiasis elimination: lessons from the past guide the future. The Lancet Infectious Diseases 10(10): 733–736. https://doi.org/10.1016/S1473-3099(10)70099-2
[10] LoVerde P.T. 2019. Schistosomiasis. In: Digenetic trematodes. (Eds. R. Toledo, B. Fried). Vol 1154. Springer International Publishing: 45–70. https://doi.org/10.1007/978-3-030-18616-6_3
[11] Engels D., Chitsulo L., Montresor A., Savioli L. 2002. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Tropica 82(2): 139–146. https://doi.org/10.1016/s0001-706x(02)00045-1
[12] Szekeres C., Galletout P., Jaureguiberry S., Crickx E., Monsel G., Chabriat H., Jouvent E. 2013. Neurological presentation of schistosomiasis. Lancet 381(9879): 1788. https://doi.org/10.1016/S0140-6736(13)60317-7
[13] Vale T.C., de Sousa-Pereira S.R., Ribas J.G., Lambertucci J.R. 2012. Neuroschistosomiasis mansoni: literature review and guidelines. Neurologist 18(6): 333–342. https://doi.org/10.1097/NRL.0b013e3182704d1e
[14] McManus D.P., Dunne D.W., Sacko M., Utzinger J., Vennervald B.J., Zhou X.N. 2018. Schistosomiasis. Nature Reviews Disease Primers 4(1): 13. https://doi.org/10.1038/s41572-018-0013-8
[15] Coyle C.M. 2013. Schistosomiasis of the nervous system. Handbook of Clinical Neurology 114: 271–281. https://doi.org/10.1016/B978-0-444-53490-3.00022-4
[16] Nelwan M.L. 2019. Schistosomiasis: life cycle, diagnosis, and control. Current Therapeutic Research, Clinical and Experimental 91: 5–9. https://doi.org/10.1016/j.curtheres.2019.06.001
[17] Colley D.G., Bustinduy A.L., Secor W.E., King C.H. 2014. Human schistosomiasis. Lancet 383(9936): 2253–2264. https://doi.org/10.1016/S0140-6736(13)61949-2
[18] Ross A.G., McManus D.P., Farrar J., Hunstman R.J., Gray D.J., Li Y.S. 2012. Neuroschistosomiasis. Journal of Neurology 259(1): 22–32. https://doi.org/10.1007/s00415-011-6133-7
[19] Carod-Artal F.J. 2010. Neuroschistosomiasis. Expert Review of Anti-infective Therapy 8(11): 1307–1318. https://doi.org/10.1586/eri.10.111
[20] Jaber O.I., Kirby P.A. 2013. Spinal cord schistosomiasis. American Journal of Clinical Pathology 140(1): 33–36. https://doi.org/10.1309/AJCPQR0ELSAAWJHW
[21] Adeel A.A. 2015. Spinal cord schistosomiasis. Sudanese Journal of Paediatrics 15(2): 23–28.
[22] Joshi T.N., Yamazaki M.K., Zhao H., Becker D. 2010. Spinal schistosomiasis: differential diagnosis for acute paraparesis in a U.S. resident. Journal of Spinal Cord Medicine 33(3): 256–260. https://doi.org/10.1080/10790268.2010.11689703
[23] Algahtani H.A., Aldarmahi A.A., Al-Rabia M.W., Baeesa S.S. 2014. Acute paraplegia caused by Schistosoma mansoni. Neurosciences (Riyadh) 19(1): 47–51.
[24] de Wilton A., Aggarwal D., Jäger H.R., Manji H., Chiodini P.L. 2021. Delayed diagnosis of spinal cord schistosomiasis in a non-endemic country: a tertiary referral centre experience. PLoS Neglected Tropical Diseases 15(2): e0009161. https://doi.org/10.1371/journal.pntd.0009161
[25] Cimini A., Ricci M., Gigliotti P.E., Pugliese L., Chiaravalloti A., Danieli R., Schillaci O. 2021. Medical imaging in the diagnosis of schistosomiasis: a review. Pathogens 10(8): 1058. https://doi.org/10.3390/pathogens10081058
[26] Carod Artal F.J. 2012. Cerebral and spinal schistosomiasis. Current Neurology and Neuroscience Reports 12(6): 666–674. https://doi.org/10.1007/s11910-012-0305-4
